QUELLENANGABEN
- Hoppe HD, Lobmann R: Medizin & Praxis 2008; Spezial Mai, Chronische Wunden: 77–82
- Fleischmajer, R “Human dermal glycosaminglycans and aging, 1972
- Meyer LJ, Stern R “Age-dependent changes of hyaluronan in human skin“, J Invest Dermatol. 1994 Mar; 102(3):385-9
- Dowsett, C, Newton H “Wound bed preparation: TIME in practice” WOUNDS UK, 2005, 1. Jg., Nr. 3, S. 58
- Lokaltherapie chronischer Wunden bei Patienten mit den Risiken periphere arterielle Verschlusskrankheit, Diabetes mellitus, chronisch venöse Insuffizienz; Registernummer 091 – 001; Stand: 12.06.2012, gültig bis 30.04.2016
- Onesti MG, Fioramonti P, Fino P, Sorvillo V, Carella S, Scuderi N. “Effect of enzymatic debridement with two different collagenases versus mechanical debridement on chronic hard-to-heal wounds.” Int Wound J 2015; doi: 10.1111/iwj.12421
- Onesti MG et al.: Eur Rev Med Pharmacol Sci. 2013; 17(2): 210–6
- Onesti MG, Fino P, Ponzo I, Ruggieri M, Scuderi N. “Non-surgical treatment
of deep wounds triggered by harmful physical and chemical agents: a successful combined use of collagenase and hyaluronic acid” 2014 - Karousou E. et al.: Eur Journal of Acne and Relate Diseases 2015; 6
- Gravante G et al.: Eur Rev Med Pharmacol Sci 2013; 17(20): 2721–7
- Schlesinger T, Powell CR.: J Clin Aesthet Dermatol 2012; 5(10): 20–23
- Ortonne JP: Journal of Dermatological Treatment 1996; 0954-6634
- Wright, JB “Efficacy of topical silver against fungal burn wound pathogens” 1999
- Lansdown, ABG “A Pharmacological and Toxicological Profile of Silver as an Antimicrobial Agent in Medical Devices” 2010
- Costagliola M, Agrosi M. Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs. silver sulfadiazine alone. Curr Med Res Opin 2005; 21:1235–1240
- Koller J. Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: a double blind, clinical study. Drugs Exp Clin Res
2004; 30:183–190 - Zanetti E. & Calosso A. [Prevenzione e trattamento delle Lesioni da Decubito]. Lauri Ed. Milano, 2000
- Peghetti A, Bellingeri A, Pomponio G, Sansoni J, Paladino D. Efficacia dell’acido ialuronico associate alla sulfadiazina (connettivina plus) nel trattamento delle lesioni da pressione: uno studio di coorte osservazionale prospettico. Professioni Infermieristiche 2009; 62:67–77
- Gibson D, Cullen B, Legerstee R, Harding KG, Schultz G. „MMP’s made easy“, Wounds International Volume 1 | Issue 1 | November 2009
- Winter, GD: Nature 1962; 193: 293-4
- Liguori V et al. Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother. Oncol 1997; 42:155–161 Radiother Oncol. 1997 Feb; 42(2):155–61
- Migliore A et al. Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa) in symptomatic osteoarthritis oft he hip: a prospective cohort study. Arch Orthop Trauma Surg (2011) 131(12):1677-1685.
- Summary of Product Characteristics HyalOne®
- Schieb F et al. Arthritis + Rheuma 2003; 23: 338-340
- Foti C et al. Eur J Phys Rehabil Med 2011;47:1-9
- Priano F, Guelfi M. Artroscopia 2007; 8(1): 3-12
- Finelli I et al. Biorheology, 2011; 48(5):263
- Finelli I et al. Macromol Biosci 2009; 9: 646-653
- Fidia; Data on file
- Goldberg VM et al.: Osteoarthritis Cartilage, 13: 216–224; 2005
- Pavelka K et al. Acta Chir Orthop Traumatol Cech. 1995; 62 (6): 362–366.
